ELISABETH DUER: Open Payments
NPI 1790380699 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 48 payments from 17 companies in 2025. Trend: 2023 $285 · 2024 $691 · 2025 $1,158
Food & beverage: $1,089Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $216 |
| AstraZeneca Pharmaceuticals LP | 8 | $204 |
| Astellas Pharma US Inc | 4 | $136 |
| Lilly USA, LLC | 4 | $89 |
| Novo Nordisk Inc | 4 | $86 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Amgen Inc. | 5 | $75 |
| PFIZER INC. | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Abbott Laboratories | 1 | $30 |
Products named: QULIPTA, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA, UBRELVY, MOUNJARO, Veozah, OTEZLA.
Industry payments across FL — which companies pay providers there.
